THE UK GOVERNMENT’S RESPONSE to Brexit and its failure to iron out key agreements after nearly a year outside the Single Market and Customs Union, are fuelling constant uncertainty over many aspects of health and social care in the UK, says a new report from the Nuffield Trust.

This video from January is US Pharma industry lobby telling US trade negotiators that US-UK trade deal is “an important opportunity” to deal with “artificially depressed prices” in UK - “dictated” via our “primary payer” system

When President Donald Trump arrived in the United Kingdom this week, he landed bang in the middle of a huge political fight about the country's National Health Service.

Irish foreign minister hits out at Brexit minister over provocative article on Northern Ireland protocol

Companies should ensure six weeks’ worth of drugs for end of transition period, DHSC says.

A fast-track visa route for Nobel prize laureates and other award-winners in science, engineering, the humanities and medicine has failed to attract any applicants.

The British government has urged medicine suppliers to prepare for the country’s exit from the EU single market and customs union on Dec. 31 by building up six weeks’ worth of stocks in case of disruption to imports.

The UK’s MHRA may have to lay off about 300 of its 1,200 employees, thanks to a decline in income due to reduced medical product submissions following Brexit, spurring anger among unions across the island.

Prime Minister Boris Johnson says he doesn’t want border ‘restrictions’ for medicines, but that’s what his government is doing.

The UK has been warned by the pharmaceutical industry that some stockpiles of medical supplies have been "used up entirely" by the virus.

The UK has been warned by the pharmaceutical industry that some stockpiles of medical supplies have been "used up entirely" by the virus.

But experts have warned that the deadline of 1 September set for the deal is a "tight" timeframe.

The government has set out a plan to overhaul EU laws copied over after Brexit - a move it says will cut unnecessary "red tape" for businesses.

Doctors call for more transparency amid fears of shortages, especially of insulin.

Envoys sidestep ban on discussing drug prices by referring to controversial subject ‘valuing innovation’.

The well known logistics company, chaired by German billionaire Klaus-Michael Kühne, has been tasked with delivering “medicines and medical goods which are at risk of shortage” into the UK “within days”.

The UK has given the EU a new deadline of two weeks to agree to axe trade checks introduced by the Brexit deal for Northern Ireland, or risk unilateral action by London.

New EU rules come into force today, which could leave British patients exposed after March 29.

The UK’s medicines and devices regulator will stop work that “does not add value” and lose over 100 full time equivalent staff posts as part of its post-Brexit cost cutting drive, a leaked consultation document seen by The BMJ shows. / But experts warned that plans to streamline regulation to speed up the development and approval of new drugs for patients’ benefit carried potential safety risks.

Fears extra expense and paperwork caused by Brexit will make Britain unattractive to global drugmakers.

The UK and EU have reached agreement on how rules in the withdrawal agreement will be implemented, particularly in relation to Northern Ireland.

'What they will actually target is the process by which we control pharmaceutical pricing. That is where they will be pushing - we have to resist them'

The U.K. government urged pharmaceutical companies to stockpile a six-week supply of medicines before the country finally leaves the European Union’s customs regime at the end of the year, in an effort to avoid shortages of drugs.

British pharmacists are struggling to get their hands on certain medicines for cancer, epilepsy, diabetes and menopause as drug supply issues intensify in the country.